Researches

Faculty of Pharmacy

Assiut University

# Title Department Research Year
91 Synthesis, enzyme inhibition, and docking studies of new Schiff bases of disalicylic acid methylene-based derivatives as dual-target antibacterial agents Department of Pharmaceutical Organic Chemistry 2024
92 Spectrofluorimetric determination of Alogliptin benzoate through condensation with ninhydrin and phenylacetaldehyde: application to dosage form and rat plasma Department of Pharmaceutical Analytical Chemistry 2024
93 Design and preparation of a fluorescent molecularly imprinted membrane for the selective detection of pepsin enzyme as a biomarker for gastroesophageal reflux disease 2024
94 Therapeutic effects of myrrh extract and myrrh-based silver nanoparticles on Trichinella spiralis-infected mice: parasitological, histopathological, and immunological (IFN-γ, IL-10, and MMP-9) investigations 2024
95 Design, synthesis, and antiproliferative activity of new 1, 2, 3-triazole/quinazoline-4-one hybrids as dual EGFR/BRAF V600E inhibitors Department of Pharmaceutical Organic Chemistry 2024
96 Evaluation of the therapeutic potential of novel nanoparticle formulations of glutathione and virgin coconut oil in an experimental model of carbon tetrachloride-induced liver … Department of Pharmacology 2024
97 Discovery of new Schiff bases of the disalicylic acid scaffold as DNA gyrase and Topoisomerase IV inhibitors endowed with antibacterial properties Department of Pharmaceutical Organic Chemistry 2024
98 Development of Highly Sensitive Fluorescent Sensors for Separation-Free Detection and Quantitation Systems of Pepsin Enzyme Applying a Structure-Guided Approach Department of Pharmaceutical Analytical Chemistry 2024
99 Nanostructured gold-embedded porous carbon black nanoceramic film coating on pencil graphite rods: An innovative disposable ultrasensitive sensor for monitoring dopamine Department of Pharmaceutical Analytical Chemistry 2024
100 Design, synthesis, and antiproliferative activity of new 1,2,3-Triazole/Quinazoline-4-one hybrids as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2024